Vivos Therapeutics (VVOS) EPS (Weighted Average and Diluted) (2022 - 2026)
Vivos Therapeutics (VVOS) reported EPS (Weighted Average and Diluted) of -$0.52 for Q1 2026, down 15.56% year-over-year from -$0.62 in Q1 2025, and up 10.34% quarter-over-quarter from -$0.58 in Q4 2025.
Vivos Therapeutics (VVOS) EPS (Weighted Average and Diluted) (2022 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 5 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.52 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.52, down 15.56% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.14 (down 23.7% YoY), and the FY2025 annual result was -$2.07, up 6.76% from the prior year.
- EPS (Weighted Average and Diluted) grew to -$0.52 in Q1 2026 per VVOS's latest filing, from -$0.58 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at -$0.28 in Q4 2024 and troughed at -$6.4 in Q3 2022.
- A 5-year average of -$1.77 and a median of -$0.59 in 2025 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2023 and 2024: EPS (Weighted Average and Diluted) sank 1300.0% in 2023, then jumped 90.82% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$5.0 in 2022, then surged by 39.0% to -$3.05 in 2023, then jumped by 90.82% to -$0.28 in 2024, then plunged by 107.14% to -$0.58 in 2025, then gained by 10.34% to -$0.52 in 2026.
- Business Quant data shows VVOS's EPS (Weighted Average and Diluted) at -$0.52 in Q1 2026, -$0.58 in Q4 2025, and -$0.49 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Vivos Therapeutics | 7.39 Mn | 5.16 Mn | 3.06 Mn | -0.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.52 |
| Dec 31, 2025 | -0.58 |
| Sep 30, 2025 | -0.49 |
| Jun 30, 2025 | -0.55 |
| Mar 31, 2025 | -0.45 |
| Dec 31, 2024 | -0.28 |
| Sep 30, 2024 | -0.40 |
| Jun 30, 2024 | -0.60 |
| Mar 31, 2024 | -1.63 |
| Dec 31, 2023 | -3.05 |
| Sep 30, 2023 | -1.75 |
| Jun 30, 2023 | -4.62 |
| Mar 31, 2023 | -1.72 |
| Dec 31, 2022 | -5.00 |
| Sep 30, 2022 | -6.40 |
| Jun 30, 2022 | -0.33 |